These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17109289)

  • 21. [Viruses and antiviral drug resistance].
    Hovi T; Järvinen A; Pyhälä R; Ristola M; Salminen M
    Duodecim; 2002; 118(9):911-8. PubMed ID: 12238169
    [No Abstract]   [Full Text] [Related]  

  • 22. Intermittent treatment of severe influenza.
    Deecke L; Dobrovolny HM
    J Theor Biol; 2018 Apr; 442():129-138. PubMed ID: 29355540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.
    Barr IG; Hurt AC; Iannello P; Tomasov C; Deed N; Komadina N
    Antiviral Res; 2007 Feb; 73(2):112-7. PubMed ID: 16963130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus: January 2010.
    Wkly Epidemiol Rec; 2009 Feb; 85(6):37-40. PubMed ID: 20151493
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification of genetic determinants of influenza A virus resistance to adamantanes and neuraminidase inhibitors using biological microarray.
    Heydarov RN; Fesenko EE; Shaskolskiy BL; Klotchenko SA; Vasin AV; Titov SV; Dementieva EI; Zasedatelev AS; Mikhailovich VM; Kiselev OI
    Dokl Biochem Biophys; 2015; 460():4-8. PubMed ID: 25772979
    [No Abstract]   [Full Text] [Related]  

  • 26. The evolution of influenza resistance and treatment.
    Weinstock DM; Zuccotti G
    JAMA; 2009 Mar; 301(10):1066-9. PubMed ID: 19255112
    [No Abstract]   [Full Text] [Related]  

  • 27. Influenza reverse genetics: dissecting immunity and pathogenesis.
    Ye S; Evans JG; Stambas J
    Expert Rev Mol Med; 2014 Feb; 16():e2. PubMed ID: 24528628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2016 Oct; 91(41):469-84. PubMed ID: 27758094
    [No Abstract]   [Full Text] [Related]  

  • 29. Shift shown in influenza A adamantane resistance.
    Shah RC
    JAMA; 2006 Oct; 296(13):1585-6; author reply 1586-7. PubMed ID: 17018799
    [No Abstract]   [Full Text] [Related]  

  • 30. Discovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral Resistance.
    Wee KB; Lee RT; Lin J; Pramono ZA; Maurer-Stroh S
    PLoS Comput Biol; 2016 Jan; 12(1):e1004663. PubMed ID: 26771381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adamantane and neuraminidase inhibitor resistance among circulating human influenza A viruses in Cuba during 2006-2010.
    Piñón A; Acosta B; Valdés O; Pérez A; Muné M; Arencibia A; Savón C; Goyenechea A; Oropesa S; González G; González G; Hernández B
    Int J Antimicrob Agents; 2013 Jul; 42(1):97-8. PubMed ID: 23648224
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug resistance among influenza A viruses isolated in Italy from 2000 to 2005: are the emergence of Adamantane-resistant viruses cause of concern?
    Ansaldi F; Valle L; Amicizia D; Banfi F; Pastorino B; Sticchi L; Icardi G; Gasparini R; Crovari P
    J Prev Med Hyg; 2006 Mar; 47(1):1-3. PubMed ID: 17061402
    [No Abstract]   [Full Text] [Related]  

  • 33. Infectious diseases. Genetic analyses suggest bird flu virus is evolving.
    Normile D
    Science; 2005 May; 308(5726):1234-5. PubMed ID: 15919958
    [No Abstract]   [Full Text] [Related]  

  • 34. Update on influenza vaccination for the 2005-2006 season. An Advisory Committee Statement (ACS).
    Advisory Committee On Immunization (NACI)
    Can Commun Dis Rep; 2006 Mar; 32(ACS-2):1-3. PubMed ID: 16710946
    [No Abstract]   [Full Text] [Related]  

  • 35. Within-Host Evolution of Human Influenza Virus.
    Xue KS; Moncla LH; Bedford T; Bloom JD
    Trends Microbiol; 2018 Sep; 26(9):781-793. PubMed ID: 29534854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
    Li F; Ma C; Hu Y; Wang Y; Wang J
    ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
    Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
    Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommended composition of influenza virus vaccines for use in the 2016 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2015 Oct; 90(41):545-59. PubMed ID: 26454888
    [No Abstract]   [Full Text] [Related]  

  • 39. Gaps in the Clinical Management of Influenza: A Century Since the 1918 Pandemic.
    Uyeki TM; Fowler RA; Fischer WA
    JAMA; 2018 Aug; 320(8):755-756. PubMed ID: 30073287
    [No Abstract]   [Full Text] [Related]  

  • 40. 2012-2013 influenza update: hitting a rapidly moving target.
    Jin XW; Mossad SB
    Cleve Clin J Med; 2012 Nov; 79(11):777-84. PubMed ID: 23125327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.